Why scientists are racing to develop more COVID antivirals
Why scientists are racing to develop more COVID antivirals
About this item
Full title
Why scientists are racing to develop more COVID antivirals
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Nature (London), 2022-01, Vol.601 (7894), p.496-496
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
The first crop of antivirals against SARS-CoV-2 is promising. But new drugs will be needed to counter the looming threat of resistance.
The first crop of antivirals against SARS-CoV-2 is promising. But new drugs will be needed to counter the looming threat of resistance.
Alternative Titles
Full title
Why scientists are racing to develop more COVID antivirals
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2622283992
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2622283992
Other Identifiers
ISSN
0028-0836
E-ISSN
1476-4687
DOI
10.1038/d41586-022-00112-8
